Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesHepatotoxicity during low-dose flutamide treatment for hirsutism
Gynecological Endocrinology, 06/29/09
Castelo-Branco C et al. - The potential of flutamide to act as a potent hepatotoxin should be kept in mind when treatment with this drug is being planned. This case reminds us that patients who are receiving flutamide should be regularly monitored for liver function. If drug-induced liver injury is suspected, flutamide must be discontinued promptly to avoid progression of liver injury.
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Liver disease: Early signs you may be missing
APCToday, 10/21/09
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09
Severe sepsis in cirrhosis
Hepatology, 11/04/09
Sponsor
Article Search
Sponsor